George Yu
Nessuna posizione attualmente
Storia della carriera di George Yu
Precedenti posizioni note di George Yu
Società | Posizione | Inizio | Fine |
---|---|---|---|
MEDISUN PRECISION MEDICINE LTD. | Direttore/Membro del Consiglio | 29/08/2012 | 19/01/2017 |
Amministratore Delegato | 29/08/2012 | 19/01/2017 | |
Direttore Finanziario/CFO | 29/08/2012 | 19/01/2017 | |
Fondatore | 29/08/2012 | 19/01/2017 | |
Presidente | 29/08/2012 | 19/01/2017 | |
SinoBiomed, Inc.
SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Direttore/Membro del Consiglio | 04/02/2011 | 04/08/2011 |
Direttore Finanziario/CFO | 16/06/2011 | 04/08/2011 | |
Presidente | 03/09/2010 | 16/06/2011 | |
LOGIQ, INC. | Direttore/Membro del Consiglio | 01/03/2012 | - |
Direttore Finanziario/CFO | 01/03/2012 | 20/12/2012 | |
Presidente | 01/03/2012 | 20/12/2012 |
Formazione di George Yu
Eberhard Karls Universität Tübingen | Doctorate Degree |
Columbia Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Cina | 2 |
Germania | 2 |
Posizioni
Director/Board Member | 3 |
Director of Finance/CFO | 3 |
President | 3 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
LOGIQ, INC. | Technology Services |
Aziende private | 2 |
---|---|
SinoBiomed, Inc.
SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Health Technology |
Medisun Precision Medicine Ltd.
Medisun Precision Medicine Ltd. BiotechnologyHealth Technology Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands. | Health Technology |
- Borsa valori
- Insiders
- George Yu
- Esperienza